English   español  

Navegación por Autor Matous, Jeffrey V.

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 1 a 3 de 3
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
openAccessIbrutinib Plus Rituximab_Buske_PV_Art2022.pdf.jpg2022Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström’s Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE StudyBuske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Véronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V.; Tam, Constantine S.; Heffner, Leonard T.; Varettoni, Marzia; Palomba, M. Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Steven P.; Ping, Jerry; Hauns, Bernhard; Arango-Hisijara, Israel; Dimopoulos, Meletios A.artículo
openAccess23-feb-2023Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemiaBuske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Véronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V.; Heffner, Leonard T.; Varettoni, Marzia; Palomba, M. Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Steven P.; Ping, Jerry; Hauns, Bernhard; Arango-Hisijara, Israelartículo
openAccessDS_JCO.21.00838.pdf.jpg2022Supplementary files of the article Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström’s Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study [Dataset]Buske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Véronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V.; Tam, Constantine S.; Heffner, Leonard T.; Varettoni, Marzia; Palomba, M. Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Steven P.; Ping, Jerry; Hauns, Bernhard; Arango-Hisijara, Israel; Dimopoulos, Meletios A.dataset